首页|HIV/AIDS患者合并宫颈癌的诊治研究进展

HIV/AIDS患者合并宫颈癌的诊治研究进展

扫码查看
宫颈癌(CC)是艾滋病相关肿瘤,在HIV感染女性中,宫颈癌是最常见的恶性肿瘤之一.相较于未感染HIV的患者,HIV阳性的女性患宫颈癌的风险大大增加,并且诊断宫颈癌时肿瘤分期更晚.直至目前,HIV阳性的宫颈癌仍没有标准的治疗方案,治疗难度较大,预后尚有争议.本文针对宫颈癌合并HIV感染患者的发病、临床特点、治疗及预后情况进行全面阐述,为这类人群的临床诊疗提供线索.
Research progress in the diagnosis and treatment of HIV/AIDS patients with cervical cancer
Cervical cancer(CC)is an AIDS-related tumor and is one of the most common malignancies in women with HIV infection.In comparison to patients without HIV,those with HIV have a markedly elevated risk of developing cervical cancer and are diagnosed at a more advanced stage.At present,there is no standard treatment for HIV-positive cervical cancer,which is challenging to treat,and the prognosis remains controversial.This article provides a comprehensive description of the pathogenesis,clinical characteristics,treatment and prognosis of cervical cancer patients with HIV HIV-infected,so as to provide clues for the clinical diagnosis and treatment of this population.

Cervical cancer(CC)HIVclinical characteristicstherapyprognosis

王嘉璇、李凤虎

展开 >

贵州医科大学附属肿瘤医院肿瘤科,贵阳 550008

贵州医科大学临床医学院肿瘤学教研室,贵阳 550025

宫颈癌 艾滋病病毒 临床特点 治疗 预后

2024

中国艾滋病性病
中国性病艾滋病防治协会

中国艾滋病性病

CSTPCD北大核心
影响因子:1.292
ISSN:1672-5662
年,卷(期):2024.30(12)